Bradykinin-induced functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors

Amol M Patwardhan, Kelly A. Berg, Armen N. Akopain, Nathaniel A. Jeske, Nikita Gamper, William P. Clarke, Kenneth M. Hargreaves

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Peripheral opioid analgesia is increased substantially after inflammation. We evaluated the hypothesis that an inflammatory mediator, bradykinin (BK), evokes functional competence of the δ-opioid receptor (DOR) for inhibiting trigeminal ganglia (TG) sensory neurons. We also evaluated whether BK evokes trafficking of the DOR to the plasma membrane. Rat TG cultures were pretreated with BK(10 μM) or vehicle, and the effects of DOR agonists ([D-Pen 2,5]-enkephalin or [D-Ala2, D-Leu5]-enkephalin) on BK (10 μM)/prostagladin E2 (PGE2; 1 μM)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2 (1 μM)-stimulated cAMP accumulation were measured. The effect of BK treatment on opioid receptor trafficking was evaluated by DOR immunohistochemistry, cell-surface DOR biotinylation, and live imaging of neurons transfected with mDOR-green fluorescent protein. BK pretreatment rapidly and significantly increased DOR agonist inhibition of evoked iCGRP release and cAMP accumulation. These effects of BK pretreatment were blocked by a B2 receptor antagonist (HOE-140; 10 μM) or a protein kinase C (PKC) inhibitor [bisindolymaleimide (BIS); 1 μM]. Moreover, BK treatment rapidly and significantly increased the accumulation of DOR in the plasma membrane. However, BK-induced trafficking of DOR was not reversed by pretreatment with BIS, nor was trafficking evoked by application of a PKC activator PMA (200 nM). These data suggest that BK, in a PKC-dependent manner, induces rapid functional competence of DOR for inhibiting TG nociceptors and in a PKC-independent manner rapidly induces trafficking of DOR to the plasma membrane. These findings indicate that exposure to certain inflammatory mediators rapidly alters the signaling properties and neuronal localization of DOR, possibly contributing to peripheral opioid analgesia.

Original languageEnglish (US)
Pages (from-to)8825-8832
Number of pages8
JournalJournal of Neuroscience
Volume25
Issue number39
DOIs
StatePublished - Sep 28 2005
Externally publishedYes

Fingerprint

Nociceptors
Opioid Receptors
Bradykinin
Mental Competency
Trigeminal Ganglion
Protein Kinase C
Calcitonin Gene-Related Peptide
Cell Membrane
Analgesia
Opioid Analgesics
D-Penicillamine (2,5)-Enkephalin
Biotinylation
Protein C Inhibitor
Sensory Receptor Cells
Protein Kinase Inhibitors
Green Fluorescent Proteins
Immunohistochemistry
Inflammation
Neurons

Keywords

  • δ-opioid receptor
  • Bradykinin
  • Nociceptor
  • Pain
  • Trafficking
  • Trigeminal

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Bradykinin-induced functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors. / Patwardhan, Amol M; Berg, Kelly A.; Akopain, Armen N.; Jeske, Nathaniel A.; Gamper, Nikita; Clarke, William P.; Hargreaves, Kenneth M.

In: Journal of Neuroscience, Vol. 25, No. 39, 28.09.2005, p. 8825-8832.

Research output: Contribution to journalArticle

Patwardhan, Amol M ; Berg, Kelly A. ; Akopain, Armen N. ; Jeske, Nathaniel A. ; Gamper, Nikita ; Clarke, William P. ; Hargreaves, Kenneth M. / Bradykinin-induced functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors. In: Journal of Neuroscience. 2005 ; Vol. 25, No. 39. pp. 8825-8832.
@article{39caa143e72048268b5ada229d4e18d6,
title = "Bradykinin-induced functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors",
abstract = "Peripheral opioid analgesia is increased substantially after inflammation. We evaluated the hypothesis that an inflammatory mediator, bradykinin (BK), evokes functional competence of the δ-opioid receptor (DOR) for inhibiting trigeminal ganglia (TG) sensory neurons. We also evaluated whether BK evokes trafficking of the DOR to the plasma membrane. Rat TG cultures were pretreated with BK(10 μM) or vehicle, and the effects of DOR agonists ([D-Pen 2,5]-enkephalin or [D-Ala2, D-Leu5]-enkephalin) on BK (10 μM)/prostagladin E2 (PGE2; 1 μM)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2 (1 μM)-stimulated cAMP accumulation were measured. The effect of BK treatment on opioid receptor trafficking was evaluated by DOR immunohistochemistry, cell-surface DOR biotinylation, and live imaging of neurons transfected with mDOR-green fluorescent protein. BK pretreatment rapidly and significantly increased DOR agonist inhibition of evoked iCGRP release and cAMP accumulation. These effects of BK pretreatment were blocked by a B2 receptor antagonist (HOE-140; 10 μM) or a protein kinase C (PKC) inhibitor [bisindolymaleimide (BIS); 1 μM]. Moreover, BK treatment rapidly and significantly increased the accumulation of DOR in the plasma membrane. However, BK-induced trafficking of DOR was not reversed by pretreatment with BIS, nor was trafficking evoked by application of a PKC activator PMA (200 nM). These data suggest that BK, in a PKC-dependent manner, induces rapid functional competence of DOR for inhibiting TG nociceptors and in a PKC-independent manner rapidly induces trafficking of DOR to the plasma membrane. These findings indicate that exposure to certain inflammatory mediators rapidly alters the signaling properties and neuronal localization of DOR, possibly contributing to peripheral opioid analgesia.",
keywords = "δ-opioid receptor, Bradykinin, Nociceptor, Pain, Trafficking, Trigeminal",
author = "Patwardhan, {Amol M} and Berg, {Kelly A.} and Akopain, {Armen N.} and Jeske, {Nathaniel A.} and Nikita Gamper and Clarke, {William P.} and Hargreaves, {Kenneth M.}",
year = "2005",
month = "9",
day = "28",
doi = "10.1523/JNEUROSCI.0160-05.2005",
language = "English (US)",
volume = "25",
pages = "8825--8832",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "39",

}

TY - JOUR

T1 - Bradykinin-induced functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors

AU - Patwardhan, Amol M

AU - Berg, Kelly A.

AU - Akopain, Armen N.

AU - Jeske, Nathaniel A.

AU - Gamper, Nikita

AU - Clarke, William P.

AU - Hargreaves, Kenneth M.

PY - 2005/9/28

Y1 - 2005/9/28

N2 - Peripheral opioid analgesia is increased substantially after inflammation. We evaluated the hypothesis that an inflammatory mediator, bradykinin (BK), evokes functional competence of the δ-opioid receptor (DOR) for inhibiting trigeminal ganglia (TG) sensory neurons. We also evaluated whether BK evokes trafficking of the DOR to the plasma membrane. Rat TG cultures were pretreated with BK(10 μM) or vehicle, and the effects of DOR agonists ([D-Pen 2,5]-enkephalin or [D-Ala2, D-Leu5]-enkephalin) on BK (10 μM)/prostagladin E2 (PGE2; 1 μM)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2 (1 μM)-stimulated cAMP accumulation were measured. The effect of BK treatment on opioid receptor trafficking was evaluated by DOR immunohistochemistry, cell-surface DOR biotinylation, and live imaging of neurons transfected with mDOR-green fluorescent protein. BK pretreatment rapidly and significantly increased DOR agonist inhibition of evoked iCGRP release and cAMP accumulation. These effects of BK pretreatment were blocked by a B2 receptor antagonist (HOE-140; 10 μM) or a protein kinase C (PKC) inhibitor [bisindolymaleimide (BIS); 1 μM]. Moreover, BK treatment rapidly and significantly increased the accumulation of DOR in the plasma membrane. However, BK-induced trafficking of DOR was not reversed by pretreatment with BIS, nor was trafficking evoked by application of a PKC activator PMA (200 nM). These data suggest that BK, in a PKC-dependent manner, induces rapid functional competence of DOR for inhibiting TG nociceptors and in a PKC-independent manner rapidly induces trafficking of DOR to the plasma membrane. These findings indicate that exposure to certain inflammatory mediators rapidly alters the signaling properties and neuronal localization of DOR, possibly contributing to peripheral opioid analgesia.

AB - Peripheral opioid analgesia is increased substantially after inflammation. We evaluated the hypothesis that an inflammatory mediator, bradykinin (BK), evokes functional competence of the δ-opioid receptor (DOR) for inhibiting trigeminal ganglia (TG) sensory neurons. We also evaluated whether BK evokes trafficking of the DOR to the plasma membrane. Rat TG cultures were pretreated with BK(10 μM) or vehicle, and the effects of DOR agonists ([D-Pen 2,5]-enkephalin or [D-Ala2, D-Leu5]-enkephalin) on BK (10 μM)/prostagladin E2 (PGE2; 1 μM)-stimulated immunoreactive calcitonin gene-related peptide (iCGRP) release or PGE2 (1 μM)-stimulated cAMP accumulation were measured. The effect of BK treatment on opioid receptor trafficking was evaluated by DOR immunohistochemistry, cell-surface DOR biotinylation, and live imaging of neurons transfected with mDOR-green fluorescent protein. BK pretreatment rapidly and significantly increased DOR agonist inhibition of evoked iCGRP release and cAMP accumulation. These effects of BK pretreatment were blocked by a B2 receptor antagonist (HOE-140; 10 μM) or a protein kinase C (PKC) inhibitor [bisindolymaleimide (BIS); 1 μM]. Moreover, BK treatment rapidly and significantly increased the accumulation of DOR in the plasma membrane. However, BK-induced trafficking of DOR was not reversed by pretreatment with BIS, nor was trafficking evoked by application of a PKC activator PMA (200 nM). These data suggest that BK, in a PKC-dependent manner, induces rapid functional competence of DOR for inhibiting TG nociceptors and in a PKC-independent manner rapidly induces trafficking of DOR to the plasma membrane. These findings indicate that exposure to certain inflammatory mediators rapidly alters the signaling properties and neuronal localization of DOR, possibly contributing to peripheral opioid analgesia.

KW - δ-opioid receptor

KW - Bradykinin

KW - Nociceptor

KW - Pain

KW - Trafficking

KW - Trigeminal

UR - http://www.scopus.com/inward/record.url?scp=25644461151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25644461151&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.0160-05.2005

DO - 10.1523/JNEUROSCI.0160-05.2005

M3 - Article

C2 - 16192372

AN - SCOPUS:25644461151

VL - 25

SP - 8825

EP - 8832

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 39

ER -